col0,col1,col2,col3,col4,col5,col6
AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors,2020-09-10,Cincinnati Children's Hospital Medical Center,National Cancer Institute,phase I clinical trial,pharmacokinetics,neurofibroma
Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis,2014-08-26,Asan Medical Center,National Institute of Allergy and Infectious Diseases,phase I clinical trial,tuberculosis,tuberculosis
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis,2015-04-07,National Institutes of Health,National Institute of Allergy and Infectious Diseases,phase I clinical trial,dermatitis,dermatitis
Bone Mass Accrual in Adolescent Athletes,2011-05-01,Massachusetts General Hospital,Massachusetts General Hospital,phase III clinical trial,Bone loss,amenorrhea
Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma,2019-12-11,Complutense University of Madrid,Celgene,phase III clinical trial,pomalidomide,multiple myeloma
"A Study to Determine Dose and Tolerability of CC-220 Monotherapy, in Combination With Dexamethasone, and in Combination With Dexamethasone and Daratumumab or Bortezomib in Subjects With Relapsed and Refractory Multiple Myeloma (MM)",2021-03-16,University of North Carolina at Chapel Hill,Celgene,phase I clinical trial,pharmacokinetics,multiple myeloma
An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Subjects With Acute Myeloid Leukemia (AML),2018-10-31,Duke University,Celgene,phase II clinical trial,safety,leukemia
